Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04887857. IPD Sharing: YES. Countries: 2. Publications: 0.
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03940352. IPD Sharing: NO. Countries: 7. Publications: 0.
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors
ClinicalTrials.gov study NCT03233074. IPD Sharing: NO. Countries: 1. Publications: 0.
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT06543381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients
ClinicalTrials.gov study NCT04216771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
ClinicalTrials.gov study NCT02781883. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells
ClinicalTrials.gov study NCT07236931. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML
ClinicalTrials.gov study NCT05473221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02198482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Amonafide in Combination With Cytarabine in Secondary AML
ClinicalTrials.gov study NCT00273884. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
ClinicalTrials.gov study NCT03597321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
ClinicalTrials.gov study NCT06191263. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04609826. IPD Sharing: YES. Countries: 4. Publications: 0.
Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing
ClinicalTrials.gov study NCT02861651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
ClinicalTrials.gov study NCT06621199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
ClinicalTrials.gov study NCT05429632. IPD Sharing: NO. Countries: 14. Publications: 0.
Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT02312102. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
ClinicalTrials.gov study NCT05404906. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML
ClinicalTrials.gov study NCT05467202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03410407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.